Fig. 6
From: The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Analysis of samples collected ON (n = 29) vs OFF (n = 132) systemic antibacterial therapies. a Significant differences were found in Shannon alpha diversity measures as measured by a paired t test. b Bray-Curtis PCoA plot of samples ON vs OFF systemic therapies. PERMANOVA reveals significant community-wide differences (p = 0.02*), as shown in the PCoA plot. Even when permutations are constrained by patient significance is observed (p = 0.04). c Significant differences in the log abundance of samples ON vs OFF systemic therapies were detected in Streptococcus (OTU2) using a paired t test